Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmet Imrali

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 7, 2015
Circulating cancer stem cells: the importance to selectMing-Hsin Yang, Ahmet Imrali, Christopher Heeschen
American Journal of Cancer Research|September 21, 2016
Rapamycin inhibits prostate cancer cell growth through cyclin D1 and enhances the cytotoxic efficacy of cisplatinAhmet Imrali, Xueying Mao, Marc Yeste-Velasco, et al.
Plos One|September 24, 2015
Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation SystemLei Xu, Xueying Mao, Ahmet Imrali, et al.
Current Protocols Essential Laboratory Techniques|December 31, 2020
Validation of a Novel, Flash-Freezing Method: Aluminum PlatformAhmet Imrali, Christine S Hughes, Abigail S Coetzee, et al.
Cancers|January 8, 2023
Differentiating Ductal Adenocarcinoma of the Pancreas from Benign Conditions Using Routine Health Records: A Prospective Case-Control StudyMohamed Zardab, Vickna Balarajah, Abhirup Banerjee, et al.
Translational Oncology|October 4, 2025
A central research portal for mining pancreatic clinical and molecular datasets and accessing biobanked samplesJorge Oscanoa, Helen Ross-Adams, Abu Z M Dayem Ullah, et al.
NPJ Precision Oncology|June 30, 2021
Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinomaMichelle R Goulart, Jennifer Watt, Imran Siddiqui, et al.
Nature Communications|September 25, 2020
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancerHemant M Kocher, Bristi Basu, Fieke E M Froeling, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 7, 2015
Circulating cancer stem cells: the importance to selectMing-Hsin Yang, Ahmet Imrali, Christopher Heeschen
American Journal of Cancer Research|September 21, 2016
Rapamycin inhibits prostate cancer cell growth through cyclin D1 and enhances the cytotoxic efficacy of cisplatinAhmet Imrali, Xueying Mao, Marc Yeste-Velasco, et al.
Plos One|September 24, 2015
Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation SystemLei Xu, Xueying Mao, Ahmet Imrali, et al.
Current Protocols Essential Laboratory Techniques|December 31, 2020
Validation of a Novel, Flash-Freezing Method: Aluminum PlatformAhmet Imrali, Christine S Hughes, Abigail S Coetzee, et al.
Cancers|January 8, 2023
Differentiating Ductal Adenocarcinoma of the Pancreas from Benign Conditions Using Routine Health Records: A Prospective Case-Control StudyMohamed Zardab, Vickna Balarajah, Abhirup Banerjee, et al.
Translational Oncology|October 4, 2025
A central research portal for mining pancreatic clinical and molecular datasets and accessing biobanked samplesJorge Oscanoa, Helen Ross-Adams, Abu Z M Dayem Ullah, et al.
NPJ Precision Oncology|June 30, 2021
Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinomaMichelle R Goulart, Jennifer Watt, Imran Siddiqui, et al.
Nature Communications|September 25, 2020
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancerHemant M Kocher, Bristi Basu, Fieke E M Froeling, et al.
Pageof 1